Once a specialty prescription is written, fulfillment can become derailed at any number of points in the process. It can be ...

Why taking proactive steps—and combing the right data sources—is critical to informed decision-making in risk management.

Steffen Lang, president, operations, executive committee member, Novartis, discusses how technology will continue to enhance operations and how it will impact patients.

Healthcare costs, insurance barriers, and medical debt are preventing patients with chronic illnesses in the US from ...

White G. Rethinking Your C&GT Value Chain: How to Ensure Readiness for Evolving Specialized Therapy Requirements. April 9, ...

Respective industry and government agendas could significantly reshape the US prescription drug market.

Steffen Lang, president, operations, executive committee member, Novartis, shares strategic insights on how pharma supply chain leaders can elevate operations to drive innovation, growth, and patient ...

How data-driven insights can help pharma companies balance their revenue management and innovation strategies—including ...

In the third part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, details the aspect of her ...

“To move at speed, you need to partner with people that are better than you.” This was just one of several memorable quotes ...

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at ...

A panel discussion breaks down ways for stakeholders to meet temperature-controlled operational demands pertaining to product ...